Prof Kenneth Broadley - BPharm PhD DSc FBPharmacolS FRSocMed
Peer reviewed articles
Broadley, K.J., Davies, R.H., Escargueil, C., Lee, A.T.L., Penson, P., Thomas, E.J. (2011). Synthesis of antagonists of muscarinic (M3) receptors. Collect. Czech. Chem. Commun. 76, 781-801. (doi:10.1135/cccc2011017)
Lauder, S.N., Taylor, P.R., Clark, S.R., Evans, R.L., Hindley, J.P., Smart, K., Leach, H., Kidd, E.J., Broadley, K.J., Jones, S.A., Wise, M.P., Godkin, A.J., O’Donnell, V., Gallimore, A.M. (2011). Paracetamol reduces influenza-induced immunopathology in a model of infection without compromising virus clearance or the generation of protective immunity. Thorax doi:10.1136/thx.2010.150318.
Broadley, K.J, Sykes, S.C, Davies, R.H. (2010). Towards a thermodynamic definition of efficacy in partial agonism: The thermodynamics of efficacy and ligand proton transfer in a G protein-coupled receptor of the rhodopsin class.Biochem Pharmacol. 80(10):1537-45.
Broadley, K.J., Blair A.E., Kidd, E.J., Bugert J.J., Ford, W.R. (2010). Bradykinin-induced lung inflammation and bronchoconstriction: role in PIV-3-induced inflammation and airways hyperreactivity J. Pharmacol. Exp. Ther. 335, 681-692.
Fehler, M., Broadley, K.J., Ford, W.R., Kidd, E.J. (2010). Identification of trace amine-associated receptors (TAAR) in the aorta and their role in vasoconstriction by β-phenylethylamine. Naunyn-Schmiedeberg’s Arch. Pharmacol. 382, 385-398.
Turner, D.L., Ferrari, N., Ford, W.R., Kidd, E.J., Paquet, L., Renzi, P., Broadley, K.J. (2010). TPI 1020, a novel anti-inflammatory, nitric oxide donating compound, potentiates the bronchodilator effects of salbutamol. Eur. J Pharmacol. 641, 213-219.
Al-Motarreb, A., Al-Habori, M., Broadley, K.J. (2010). Khat chewing, cardiovascular diseases and other internal medical problems: The current situation and directions for future research. J. Ethnopharmacol. 132, 540-548.
Smith, N., Broadley, K.J. (2010). Adenosine receptor subtypes in airways responses to inhaled ovalbumin. Pulm. Pharmacol. Ther. 23, 355-364.
Fernandez-Rodriguez,S., Broadley, K. J., Ford, W. R., Kidd, E. J. (2010). Increased muscarinic receptor activity of airway smooth muscle isolated from a model of allergic asthma. Pulm. Pharmacol. Ther. 23, 300-307.
Broadley, K.J. (2010). The vascular effects of trace amines and amphetamines. Pharmacol Ther. 125, 363-375.
Broadley, K. J., Anwar, M.A., Herbert, A.A., Fehler, M., Jones, E.M., Davies, W.E., Kidd, E.J. & Ford W.R. (2009) Effects of dietary amines on the gut and its vasculature. Br. J. Nutrition 101, 1645-1652.
Bradshaw, B., Evans, P., Fletcher, J., Lee, A.T., Mwashimba, P.G., Oehlrich, D., Thomas, E.J., Davies, R.H., Allen, B.C., Broadley, K.J., Hamrouni, A., & Escargueil, C. (2008) Synthesis of 5-hydroxy-2,3,4,5-tetrahydro-[1H]-2-benzazepin-4-ones: selective antagonists of muscarinic (M3) receptors. Org. Biomol. Chem. 6, 2138-2157.
Allen, B.P.C., Nederkoorn, P.H.J., Timmerman, H., Timms, D, Broadley, K.J. & Davies, R.H. (2008) Monocation-driven proton transfer relays within G protein-coupled receptors of the rhodopsin class and the GTP synthase mechanism. J. Mol Structure: THEOCHEM 859, 51-68.
Penson, P.E., Ford, W.R., Kidd, E.J. & Broadley, K.J. (2008)Activation of β-adrenoceptors mimics preconditioning of isolated atria and ventricles against ischaemic contractile dysfunction. Naunyn-Schmiedeberg’s Arch Pharmacol 378, 587-597.
Herbert, A.A., Kidd, E.J. & Broadley, K.J. (2008) Dietary trace amine-dependent vasoconstriction in porcine coronary artery. Br. J. Pharmacol. 155, 525-534.
Smith, N. & Broadley, K.J. (2008) Adenosine receptor subtypes in the airways responses to 5’-adenosine monophosphate inhalation. Clin. Exp. Allergy 38, 1536-1547.
Fernandez-Rodriguez, S, Ford, W.R., Broadley, K.J. & Kidd, E.J. (2008) Establishing the phenotype in novel acute and chronic murine models of allergic asthma. Int Immunopharmacol. 8, 756-763.
Penson, P.E., Ford, W.R. & Broadley, K.J. (2007) Vasopressors for cardiopulmonary resuscitation: Does pharmacological evidence support clinical practice? Pharmacol. Ther. 115, 37-55.
Baker, K.E., Herbert, A.A. & Broadley, K.J. (2007) Vasoconstriction of porcine left anterior descending coronary artery by ecstasy and cathinone is not an indirect sympathomimetic effect. Vasc. Pharmacol. 47, 10-17
Smith, N. & Broadley, K.J. (2007) Optimisation of the sensitisation conditions for an ovalbumin challenge model of asthma. Int. Immunopharmacol., 7, 183-190.
Broadley, K.J. (2006) b-Adrenoceptor responses of the airways: For better or worse? Eur. J. Pharmacol. 533, 15-27.
Yates, L., Clark, J.H. Martin, T.J., James, S., Broadley, K.J. & Kidd, E.J. (2006) Radioligand binding and functional responses of human recombinant adenosine A3 receptors. Auton. Autacoid Pharmacol.,26, 1-10.
Broadley, K.J. & Penson, P.E. (2006) Effects of hypoxia on the vasodilator activity of nifedipine and evidence of secondary pharmacological properties. Eur. J. Pharmacol., 536, 279-286.
Chidgey, S.M. & Broadley, K.J. (2005) Respiratory syncytial virus infections: characteristics and treatment. J. Pharm. Pharmacol., 57, 1371-1381.
Al-Motarreb, A., Briancon, S., Al-Jaber, N., Al-Adhi, B., Al-Jailani, F., Salek, M.S. & Broadley, K.J. (2005) Khat chewing is a risk factor for acute myocardial infarction: a case-control study. Br. J. Clin. Pharmacol., 59, 574-581.
Broadley, K.J. & Penson, P.E. (2004) The roles of a- and b-adrenoceptor stimulation in myocardial ischaemia. Auton. Autacoid Pharmacol., 24, 87-93.
Nevin, B.J. & Broadley, K.J. (2004) Comparative effects of inhaled budesonide and the NO-donating budesonide derivative, NCX 1020, against leukocyte influx and airway hyperreactivity following lipopolysaccharide challenge. Pulm. Pharmacol. Ther. 17, 219-232.
Al-Motarreb, A.L. & Broadley, K.J. (2003) Coronary and aortic vasoconstriction by cathinone, the active constituent of khat. Auton Autacoid Pharmacol., 23, 319-326.
Gardner, N.M., Yates, L. & Broadley, K.J. (2004) Effects of endogenous adenosine and adenosine receptor agonists on hypoxia-induced stunning. J. Cardiovasc. Pharmacol. 43, 358-368.
Toward, T.J. & Broadley, K.J. (2004) Early and late bronchoconstrictions, airway hyper-reactivity, leucocyte influx and lung histamine and nitric oxide after inhaled antigen: effects of dexamethasone and rolipram. Clin. Exp. Allergy 33, 91-102.
Toward, T.J., Smith, N. & Broadley, K.J. (2004) Effect of phosphodiesterase-5 inhibitor, sildenafil (Viagra), in airways disease. Am. J. Respir. Crit. Care Med. 169, 227-234.
Book Reviews/Profiles/Editorials
Broadley, K.J. (2002). Book Review: Human Pharmacology by Paul Gard. J. Pharm. Pharmacol. 54, 157-158.
Broadley, K.J. (2002). Laboratory profile: Cardiopulmonary Pharmacology Group. Bull. Br. Soc. Cardiovasc. Res., 15, 4-7.
Belvisi, M. & Broadley, K.J. (2005) Don’t forget the nose and pulmonary circulation! Editorial Current Opinion Pharmacol., 5, 211-213.
Broadley, K.J. (2006) Editorial. Muscarinic receptor pharmacology themed issue. Auton. Autacoid Pharmacol., 26, 201.
Abstracts and Conference Proceedings
Toward, T.J., Lewis-Lakelin, M.B., Burgaud, J-L & Broadley, K.J. (2001). Comparison of the inhibition by salbutamol-NO and salbutamol of the bronchoconstriction by histamine. Inflammation Research, 50 (Suppl. 3) S181.
Martin, T.J. & Broadley, K.J. (2001). Identification of bronchoconstrictor mediators released by adenosine in airways. Proc. Br. Pharmaceutical Conference, Glasgow. P. 191.
Martin, T.J. & Broadley, K.J. (2002). Exposure of a contractile response to adenosine in isolated trachea by passive sensitization. Br. J. Pharmacol. 135, 74P.
Toward, T.J., Maillard, J-Y., Boult, J.E. & Broadley,K.J. (2002). Airway function, hyperreactivity, cell influx and nitric oxide, in parainfluenza-3 infection: effect of dexamethasone and rolipram. Br. J. Pharmacol. 135, 73P.
Clark, J.H., Broadley, K.J., Hutcheson, I.R., Nicholson, R.I. & Kidd, E.J. (2002). Adenosine receptor agonists mediate the phosphorylation of mitogen activated protein kinase (MAPK) in MCF-7 human breast cancer cells. Br. J. Pharmacol. 135, 46P.
Yates, L. & Broadley, K.J. (2002). Protection by an adenosine A3 agonist from myocardial stunning induced by simulated ischaemia. Br. J. Pharmacol. 135, 139P.
Toward, T.J., Lewis-Lakelin, M.B. Burgaud, J-L. & Broadley, K.J. (2001). Comparison of the inhibition by salbutamol-NO and salbutamol of the bronchoconstriction by histamine. Proc. Br. Pharmaceutical Conference, Glasgow. (ISBN 0 85369 512 1) P.192.
Toward, T.J. & Broadley, K.J. (2001). Lung nitric oxide, histamine and leukocyte influx after antigen inhalation: relation to EAR, LAR and AHR. Br. J. Pharmacol (Pharmacology Vancouver (2001) 133, C70.
Toward, T.J. & Broadley, K.J. (2002). Adenylyl and guanylyl cyclase and PDE activities towards cAMP and cGMP in isolated lungs during LPS-induced airway reactivity changes. Br. J. Pharmacol. 135, 272P.
Nevin, B.J. & Broadley, K.J. (2002). Effects of inhaled corticosteroid on ovalbumen-challenge. Br. J. Pharmacol. 135, 273P.
Clark, J.H., Martin, T.J., Yates, L., Kidd, E.J., Nicholson, R.I. & Broadley, K.J. (2002). Characterization of transfected human adenosine A3 receptors. Br. J. Pharmacol. 136, 38P.
Nevin, B.J., Smith, N., Toward, T.J. & Broadley, K.J. (2002). Activities of nitro derivatives of steroids against histamine-induced bronchoconstriction. J. Pharm. Pharmacol.(Suppl). S98.
Baker, K. E. & Broadley, K.J. (2003). Vascular actions of ecstasy: roles of adrenergic neurones, endothelin, thromboxane, 5-HT, angiotensin and a1-adrenoceptors, Br. J. Pharmacol. 138, 166P.
Yates, L. & Broadley, K.J. (2003). The effect of adenosine A3 receptor activation on the recovery from simulated ischaemia. Br J Pharmacol 138, 141P.
Clark, J.H., Broadley, K.J., Hutcheson, I.R., Nicholson, R.I. & Kidd, E.J. (2003). Expression of adenosine receptors in MCF-7 human breast cancer cells. Br. J. Pharmacol. 138, 130P.
Nevin, B.J. & Broadley, K.J. (2003). Effects of L-arginine on neutrophil influx and airway hyperreactivity 1h after lipopolysaccharide challenge. Br. J. Pharmacol. 138, 133P.
Parija, S.C. & Broadley, K.J. (2003). 8sPT resistant component of A1 mediated negative inotropic response in presence of 4-AP is pertussis toxin sensitive. Br. J. Pharmacol. 138, 142P.
Smith, N. & Broadley, K.J. (2003) Early and late asthmatic responses to 5’-AMP and ovalbumin inhalation. Proc. Br. Pharmacol.Soc.,pA2online V1, issue 3, 039P.
Fernandez-Rodriguez, S., Broadley, K.J. & Kidd, E.J. (2004) Pharmacology of tracheal smooth muscle in males and females. Proceedings of the British Pharmacological Society.
Yates, L., Ford, W.R. & Broadley, K.J. (2004) Effect of an adenosine A3 receptor agonist on myocardial infarct size. Proc. Br. Pharmacol. Soc. pA2onlineVol1, issue 4 095P
Fernandez-Rodrigues, S., Broadley, K.J. & Kidd, E.J. (2004) Pharmacology of airway smooth muscle and cell influx in asthma. Eur. Respir. J., 24, Suppl. 48, 4222, p690s.
Smith, N. & Broadley, K.J. (2004)The airway response to eotaxin inhalation. Proc. Br. Pharmacol. Soc. pA2online, Vol 2 Issue 2, 128P.
Smith, N. & Broadley, K.J. (2004) Optimization of sensitization protocols for asthmatic responses to ovalbumin. Proc. Br. Pharmacol. Soc. pA2online, Vol 2 Issue 2, 131P.
Baker, K.E. & Broadley, K.J. (2004) Vasoconstriction by ecstasy and cathinone on pig left anterior descending coronary artery: lack of involvement of a1-receptors. Proc. Br. Pharmacol. Soc. pA2online, Vol 2 Issue 2, 054P.
Broadley, K.J. (2004) The rationale of NO-releasing drugs. In: Proc of the Ivth VIFB Conference ‘Rational Modifications of Original Drugs’ Prague 24-25th November 2004.
Smith, N. & Broadley, K.J. (2004) Role of adenosine A2a receptors in inflammatory responses to 5’-AMP. Am. J. Respir. Crit. Care Med. 169, A77.
Chidgey, S.M. & Broadley, K.J. (2006) Time course correlations of lung function, inflammation and viral titre after airways infection with parainfluenza-3. Proc. Br. Pharmacol. Soc. pA2online, 4, 124P.
John, E., Jackson, A & Broadley, K.J. (2006) Mucus production and tolerance to inhaled ovalbumin. Proc. Br. Pharmacol. Soc. pA2online, 4, 119P.
Penson, P.E, Ford, W.R., Kidd, E.J. & Broadley, K.J. (2006) Preconditioning by the b-adrenoceptor agonist, isoprenaline, in the atrium but not ventricle. Proc. Br. Pharmacol. Soc. pA2online, 4, Issue 2 115P.
John, E., Jackson, A. & Broadley, K.J. (2006) Reductions in stored mucin and airway responses to secretogogues in chronic asthma. Proc. Br. Pharmacol. Soc. pA2online, 4, Issue 2, 131P.
Fehler, M., Broadley, K. & Kidd, E. (2006) Contraction of aorta to beta-phenylethylamine not mediated by adrenoceptors. Proc. Br. Pharmacol. Soc. pA2online, 4, Issue 2, 182P
Herbert, A.A. & Broadley, K.J. (2006) Action of trace amine p-tyramine on adrenergic receptors in isolated porcine coronary artery. Proc. Br. Pharmacol. Soc. pA2online, 4, Issue 2, 104P.
Anwar, M.A., Ford, W.R. & Broadley, K.J. (2006) Mediators regulating tryptamine-induced tone of mesenteric arterial bed. Proc. Br. Pharmacol. Soc. pA2online, 4, Issue 2, 113P.
Penson, P.E., Ford, W.R. & Broadley, K.J. (2007) Vasopressors for cardiopulmonary resuscitation: Does pharmacological evidence support clinical practice? Pharmacol. Ther. 115, 37-55
John, E., Jackson, A., Sugar, R., Growcott, E. & Broadley, K.J. (2007) Development of chronic asthma demonstrating a mucus hypersecretory phenotype. Amer. J. Respir. Crit. Care Med. 175, A464
